Rhumbline Advisers Lowers Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Rhumbline Advisers decreased its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 9.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 5,995 shares of the medical instruments supplier’s stock after selling 650 shares during the period. Rhumbline Advisers owned 0.18% of Utah Medical Products worth $369,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of UTMD. Minerva Advisors LLC lifted its stake in shares of Utah Medical Products by 461.8% during the 3rd quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock worth $2,818,000 after purchasing an additional 34,794 shares during the last quarter. State Street Corp lifted its position in shares of Utah Medical Products by 0.9% during the third quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock valued at $5,434,000 after buying an additional 694 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Utah Medical Products by 10.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 69,411 shares of the medical instruments supplier’s stock valued at $4,644,000 after buying an additional 6,645 shares in the last quarter. Barclays PLC grew its position in shares of Utah Medical Products by 214.1% in the 3rd quarter. Barclays PLC now owns 4,574 shares of the medical instruments supplier’s stock worth $306,000 after buying an additional 3,118 shares during the last quarter. Finally, BNP Paribas Financial Markets grew its position in shares of Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after buying an additional 566 shares during the last quarter. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Up 0.7 %

NASDAQ:UTMD opened at $58.72 on Monday. The firm has a 50 day moving average of $60.93 and a 200 day moving average of $63.86. Utah Medical Products, Inc. has a 52 week low of $58.05 and a 52 week high of $77.33. The stock has a market capitalization of $199.18 million, a price-to-earnings ratio of 14.87 and a beta of 0.06.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be issued a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 2.08%. The ex-dividend date of this dividend is Friday, March 14th. Utah Medical Products’s dividend payout ratio is presently 30.89%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.